A 26-year-old male patient with pachydermoperiostosis is reported. He had severe anemia with myelofibrosis. Treatment with iron, prednisolone, oxymethorone and 1 a (OH)D3were not satisfactory. But steroid pulse therapy with parenteral iron improved his anemia and pancytopenia, but was not sufficient to relieve the bone marrowfibrosis or splenomegaly. The mechanismof anemia which was considered to be multifactorial including gastro-intestinal bleeding associated with peptic ulcer or erosion and bone marrow failure due to myelofibrosis, is discussed.
Pachydermoperiostosis
(PDP), or primary hypertrophic osteoarthropathy is an uncommon disorder of bone and connective tissue growth. The disease is characterised by thickening of the skin and subcutaneous tissue, clubbing of the fingers, oily skin, periosteal reactions and cortical thickening of the limbs, and painful swollen joints. It is thought to follow an autosomal dominant inheritance with variable expressivity. The disease is markedly more prevalent in males. It was first described in 1868, and more than 100 cases have been reported in the literature to date. Here, a case of PDPwith severe anemia and myelofibrosis which was successfully treated with steroid pulse and iron therapy is described. In addition, the relationship between PDP and anemia, is discussed.
CASE REPORT
The patient was found to have anemia when he was nine yrs old, but he received no therapy. At the age of 19 yrs old, he developed easy fatigability and was found to have hypochromic, microcytic anemia (Hb 4.1 g/dl) with a low serum iron level (34 fxg/d\). He was given iron intravenously and the anemia improved (13.6 g/dl).
In Ferrokinetic study (59Fe) revealed a normal plasma iron disappearance time (PIDT 1/2: 68 min) and normal or slightly decreased iron utilization of red blood cells (%RCU:80%). Body surface count of 59Fe ( Fig. 3 ) revealed a slightly increased uptake by the spleen and a markedly decreased uptake by the bone marrow.Results of the ferrokinetic studies indicated a myelofibrotic pattern. Bone marrow scintigraphy with "mTecnetium (Tc)-sulfur colloid revealed an increased uptake by the liver and spleen, and a decrease in uptake by the bone marrow in the whole body. An upper gastrointestinal (GI) tract survey by X-ray and endoscopy revealed erosions in the stomach and a diverticulum in the duodenum. Bariumenemashowedseveral polyps of the colon.
The sella turnica looked normal from the skull X-ray. Bone structure of osteosclerosis was not noticed. During the first admission, the cause of his anemia was not identified though myelofibrosis accompanied by iron deficiency anemia was suspected. As shown in Fig. 4 Pi t s (Fig. 5A, B) . X-ray of the hands showed cortical thickening of the proximal and middle phalanges as well as metacarpals, and it also showed shortening of the right fifth middle phalange (Fig. 5C ). Pachydermoperiostosis (PDP) was then suspected for the first time. A skin biopsy of the forehead was carried out and, as shown in Figs. 6 and 7, it revealed hyperplasia of the sebaceous glands, mild perivascular infiltration of lymphocytes and an increase of collagen and elastic fibers in the true skin and subcutaneous tissues. In addition, the acid mucopolysaccharide was diffusely stained by alcian blue. From these findings, the diagnosis of PDPwas made. Additional laboratory examinations are listed in Table 2 . From December1988, the patient was started on During the fourth admission in October 1989, steroid pulse with iron and 1 a (OH)D3therapy was carried out as before. The peripheral blood picture improved; Hb increased from 7.9 to ll.6 g/dl, white A precise evaluation of his family history revealed Table 2 . Laboratory data at the third admission. The pathogenesis of PDP has not been clarified. Some possibilities such as disorders of either the endocrine, calcium kinetics or autonomic nerve function have been proposed. As for the bone changes, Venencie et al (4) reported an increased serum bone Gla-protein (BGP or osteocalcin), which is considered to be a marker for osteoblastic bone formation. But it was not elevated in the present case, and serum calcium, phosphorus, 25(OH)D3, calcitonin, parathyroid hormone were all within normal limits. Evidence of metabolic abnormality of the bone formation was not detected in the present cases. With regard to anemia, some cases of PDPwith mild anemia have been reported without detailed clarifications.
PTH-C, parathyroid hormone C-terminal (65-84); PTH-H, PTH high sensitivity (mid
As for the iron deficiency with GI tract disorders, giant mucosal folds of the stomach, hypertrophic gastritis and peptic ulcers with high serum levels of pepsinogen I and II have been reported amongpatients of PDP (5) . In the present case, the fasting serum gastrin level, basal gastric acid output, maximumgastric acid output and serum pepsinogen I were normal. However, endoscopic examinationrevealed an erosive changeand scar formation from an ulcer in the stomach. Since the stool examination for occult blood using antihuman hemoglobin antibody was occasionally positive, his anemia may, at least in part, be attributed to the blood loss in the GI tract. The fact that both his father and cousin also showed iron deficiency anemia and had histories of duodenal ulcers, suggests some genetical relationship between PDPand peptic ulcer or GI tract disorder. In the present case, since serum iron levels or serum ferritin levels did not always correlate with the Hb level and also that the anemia was normocytic and normochromic, and did not respond to iron therapy alone, indicates that some other additional factors seem to have been operating as the cause of his anemia.
On the other hand, it is also knownthat anemia is sometimes associated with marble bone disease (osteopetrosis), in which medullary cavities are narrowed, similar to that in PDP. Thus the anemia accompanied by PDP may be, in part, due to the same mechanismas in marble bone disease.
Myelofibrosis was seen in the present case. However, the bone marrow was hypocellular with a decreased number of megakaryocytes, and chromosomeanalysis was normal. These findings are not compatible with myelofibrosis with myeloid metaplasia (MMM)which is a clonal disorder. Thus, in the present case, it is possibly secondary fibrosis associated with PDP, and may reflect an advanced phase of the natural course of PDPthat also caused the pancytopenia.
According to our knowledge, the development of anemia associated with myelofibrosis in PDP patients has been reported in only five cases (4, (6) (7) (8) . These cases are summarized in Table 3 In the treatment of anemia, we first tried the typical doses of prednisolone, oxymetholone or iron, but the effects were not satisfactory. Treatment with iron alone can be effective in mild anemia as it was with the patient's cousin, however in severe anemia as that of the present case in which bone marrow failure mayhave a role in addition to the iron deficiency, treatment with iron alone is insufficient. In the present case, intravenous administration of steroid and iron improved his anemia. In juvenile osteopetrosis, effective treatment of anemia or skeletal complications using steroids has been reported (9) . The mechanism of its efficacy is explained mainly by the direct stimulating effect on hematopoietic cells in the bone marrow (10) . It has been reported that malabsorption of GI tract has a role in the development of anemia (ll) , however, in the present case, there seemed to be no evidence of malabsorption and no difference in the effectiveness of the two methods of iron administration. We also attempted treatment with 1a(OH)D3 to improve the myelofibrosis, but no clinical effect was evident. For juvenile osteopetrosis, a clinical trial of high-dose calcitriol (32^g/day) has been carried out, and it was reported that there was biological evidence suggesting an increased bone turnover with only slight clinical improvement (12) . In the present case, a trial using a higher dose of \ a(OH)D3 would be of interest.
Thus it seems that the mechanisms of anemias associated with PDPare multifactorial including blood loss from the GI tract, bone marrow failure by myelofibrosis or narrowing of the medullary spaces, and possibly, the presence of an inhibitor for erythropoiesis.
PDP is generally thought to be a self-limiting disease, however establishment of a treatment strategy for advanced cases which show pancytopenia as the patient reported here, is an important issue. Since steroid pulse and iron therapy showed some improvement, though transiently, this approach seems to provide some additional clues to the treatment of this rare disease. The investigation of the mechanism of increased collagen and elastic fibers in the subcutaneous tissues and the bone marrow is necessary to establish the treatment of this genetical disease.
